目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End-use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Technology
2.2.3. Application
2.2.4. Test Location
2.2.5. End-use
2.3. Competitive Insights

Chapter 3. India In Vitro Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1.1. Increasing Prevalence of In Vitro Diagnostics
3.2.1.1.2. Technological advancements in In Vitro Diagnostics
3.2.1.1.3. Surge to build patient registries for clinical trials and usage of the stored data for post-marketing surveillance
3.2.2. Market restraint analysis
3.2.2.1.1. Lack of reimbursement policies for In Vitro Diagnostics
3.3. India In Vitro Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1.1. Supplier power
3.3.1.1.2. Buyer power
3.3.1.2. Substitution threat
3.3.1.3. Threat of new entrant
3.3.1.4. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. India In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. India In Vitro Diagnostics, by Product: Market Movement Analysis
4.3. India In Vitro Diagnostics Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Instruments
4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. Reagents
4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Software
4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. India In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. India In Vitro Diagnostics, by Technology: Market Movement Analysis
5.3. India In Vitro Diagnostics Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Immunoassay
5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. Hematology
5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Clinical Chemistry
5.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million
5.4.4. Molecular diagnostics
5.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million
5.4.5. Coagulation
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million
5.4.6. Microbiology
5.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million
5.4.7. Others
5.4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million

Chapter 6. India In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. India In Vitro Diagnostics, by Test Location: Movement Analysis
6.3. India In Vitro Diagnostics Market by Test Location Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Point of Care
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. Home Care
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. India In Vitro Diagnostics Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. India In Vitro Diagnostics, by Application: Movement Analysis
7.3. India In Vitro Diagnostics Market by Application Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Infectious Diseases
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. Diabetology
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Oncology
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Cardiology
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.5. Nephrology
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.6. Autoimmune Diseases
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.7. Drug Testing
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.8. Other Applications
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. India In Vitro Diagnostics Market: End-use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. India In Vitro Diagnostics, by End-use: Market Movement Analysis
8.3. India In Vitro Diagnostics Market by End-use Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Hospitals
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2. Laboratories
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3. Home-care
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4. Others
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.4. Company Profiles
9.4.1. Abbott
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. BD.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. F.Hoffmann-La Roche Ltd
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Tranasia Bio-Madicals Ltd.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Thermo Fisher Scientific Inc.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. J Mitra &Co Pvt Ltd
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Advatech Healthcare
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Tulip Diagnostics
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Siemens Healthcare Pvt Ltd.,
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Bio-Rad Laboratories
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 India In Vitro Diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 India In Vitro Diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 India In Vitro Diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 India In Vitro Diagnostics market, by end-use type, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in India
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 In vitro diagnostics market: market outlook
Fig. 10 In vitro diagnostics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 In vitro diagnostics market driver impact
Fig. 16 In vitro diagnostics market restraint impact
Fig. 17 In vitro diagnostics market strategic initiatives analysis
Fig. 18 In vitro diagnostics market: Product movement analysis
Fig. 19 In vitro diagnostics market: Product outlook and key takeaways
Fig. 20 Instruments market estimates and forecast, 2018 - 2030
Fig. 21 Reagents market estimates and forecast, 2018 - 2030
Fig. 22 Software market estimates and forecast, 2018 - 2030
Fig. 23 In vitro diagnostics market: technology movement analysis
Fig. 24 In vitro diagnostics market: technology outlook and key takeaways
Fig. 25 Immunoassay market estimates and forecasts, 2018 - 2030
Fig. 26 Hematology market estimates and forecasts,2018 - 2030
Fig. 27 Clinical chemistry market estimates and forecasts,2018 - 2030
Fig. 28 Molecular diagnostics market estimates and forecasts,2018 - 2030
Fig. 29 Coagulation market estimates and forecasts,2018 - 2030
Fig. 30 Microbiology market estimates and forecasts,2018 - 2030
Fig. 31 In vitro diagnostics market: application movement analysis
Fig. 32 In vitro diagnostics market: application outlook and key takeaways
Fig. 33 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 34 Diabetes market estimates and forecasts,2018 - 2030
Fig. 35 Cardiology market estimates and forecasts,2018 - 2030
Fig. 36 Nephrology market estimates and forecasts,2018 - 2030
Fig. 37 Autoimmune diseases market estimates and forecasts,2018 - 2030
Fig. 38 Drug testing market estimates and forecasts,2018 - 2030
Fig. 39 Other applications market estimates and forecasts,2018 - 2030
Fig. 40 In vitro diagnostics market: end-use outlook and key takeaways
Fig. 41 Hospitals market estimates and forecast, 2018 - 2030
Fig. 42 Laboratories market estimates and forecast, 2018 - 2030
Fig. 43 Health care market estimates and forecast, 2018 - 2030
Fig. 44 Others market estimates and forecast, 2018 - 2030
Fig. 45 In vitro diagnostics market: test location movement analysis
Fig. 46 In vitro diagnostics market: test location outlook and key takeaways
Fig. 47 Point of care market estimates and forecast, 2018 - 2030
Fig. 48 Home care market estimates and forecast, 2018 - 2030
Fig. 49 Others market estimates and forecast, 2018 - 2030